Entity Common Stock, Shares Outstanding of Corvus Pharmaceuticals, Inc. from 05 May 2016 to 04 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Corvus Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 05 May 2016 to 04 Nov 2025.
  • Corvus Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 04 Nov 2025 was 74,681,872, a 16% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Corvus Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 74,681,872 +10,424,621 +16% 04 Nov 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 74,514,039 +11,962,758 +19% 07 Aug 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 68,135,796 +19,097,214 +39% 25 Mar 2025 10-K 25 Mar 2025 2024 FY
Q3 2024 64,257,251 +15,218,669 +31% 12 Nov 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 62,551,281 +13,585,419 +28% 06 Aug 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 49,038,582 +2,470,071 +5.3% 19 Mar 2024 10-K 19 Mar 2024 2023 FY
Q3 2023 49,038,582 +2,485,071 +5.3% 07 Nov 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 48,965,862 +2,412,351 +5.2% 08 Aug 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 46,568,511 +15,000 +0.03% 28 Mar 2023 10-K 28 Mar 2023 2021 FY
Q3 2022 46,553,511 +5,053 +0.01% 03 Nov 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 46,553,511 +4,132,352 +9.7% 08 Aug 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 46,553,511 +8,243,960 +22% 10 Mar 2022 10-K 10 Mar 2022 2021 FY
Q3 2021 46,548,458 +18,486,558 +66% 01 Nov 2021 10-Q 01 Nov 2021 2021 Q3
Q2 2021 42,421,159 +14,385,426 +51% 02 Aug 2021 10-Q 02 Aug 2021 2021 Q2
Q1 2021 38,309,551 +8,982,651 +31% 25 Mar 2021 10-K 25 Mar 2021 2020 FY
Q3 2020 28,061,900 -1,343,500 -4.6% 29 Oct 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 28,035,733 -1,354,667 -4.6% 30 Jul 2020 10-Q 30 Jul 2020 2020 Q2
Q1 2020 29,326,900 0 0% 09 Mar 2020 10-K 09 Mar 2020 2019 FY
Q3 2019 29,405,400 +123,314 +0.42% 29 Oct 2019 10-Q 29 Oct 2019 2019 Q3
Q2 2019 29,390,400 +192,543 +0.66% 01 Aug 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 29,326,900 +8,261,066 +39% 07 Mar 2019 10-K 07 Mar 2019 2018 FY
Q3 2018 29,282,086 +8,240,836 +39% 01 Nov 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 29,197,857 +8,263,343 +39% 02 Aug 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 21,065,834 +132,447 +0.63% 01 Mar 2018 10-K 01 Mar 2018 2017 FY
Q3 2017 21,041,250 +129,317 +0.62% 01 Nov 2017 10-Q 02 Nov 2017 2017 Q3
Q2 2017 20,934,514 +25,040 +0.12% 03 Aug 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 20,933,387 +526,531 +2.6% 10 Mar 2017 10-K 10 Mar 2017 2016 FY
Q3 2016 20,911,933 03 Nov 2016 10-Q 03 Nov 2016 2016 Q3
Q2 2016 20,909,474 04 Aug 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 20,406,856 05 May 2016 10-Q 05 May 2016 2016 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.